Smith & Nephew SNATS Shares Outstanding 2012-2025 | SNN

Smith & Nephew SNATS shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Smith & Nephew SNATS shares outstanding for the quarter ending June 30, 2025 were 0M, a 0% increase year-over-year.
  • Smith & Nephew SNATS 2024 shares outstanding were 0.438B, a 0.34% increase from 2023.
  • Smith & Nephew SNATS 2023 shares outstanding were 0.437B, a 0% decline from 2022.
  • Smith & Nephew SNATS 2022 shares outstanding were 0.437B, a 0.57% decline from 2021.
Smith & Nephew SNATS Annual Shares Outstanding
(Millions of Shares)
2024 438
2023 437
2022 437
2021 439
2020 439
2019 439
2018 438
2017 438
2016 447
2015 450
2014 450
2013 453
2012 448
2011 446
Smith & Nephew SNATS Quarterly Shares Outstanding
(Millions of Shares)
2025-06-30
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
2015-06-30
2014-12-31 449
2014-09-30 447
2014-06-30 447
2014-03-31 446
2013-12-31 450
2013-09-30 452
2013-06-30 454
2013-03-31 453
2012-12-31 449
2012-09-30 447
2012-06-30 446
2012-03-31 447
2011-12-31 446
2011-09-30 443
2011-06-30 445
2011-03-31 446
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.739B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.719B 21.52
EssilorLuxottica (ESLOY) France $140.970B 0.00
Stryker (SYK) United States $137.019B 26.29
Medtronic (MDT) Ireland $131.919B 18.28
Boston Scientific (BSX) United States $113.066B 25.01
Medline (MDLN) United States $62.139B 0.00
Lonza Group Ag (LZAGY) Switzerland $46.969B 0.00
ResMed (RMD) United States $39.571B 26.42
GE HealthCare Technologies (GEHC) United States $36.756B 17.61
Agilent Technologies (A) United States $36.736B 23.22
Koninklijke Philips (PHG) Netherlands $28.368B 18.53
Terumo (TRUMY) Japan $19.441B 21.97
Zimmer Biomet Holdings (ZBH) United States $17.819B 11.11
Insulet (PODD) United States $17.019B 52.82
Baxter (BAX) United States $11.170B 9.02
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $8.133B 29.24
Demant (WILYY) Denmark $6.521B 0.00
Envista Holdings (NVST) United States $4.785B 24.25
Lantheus Holdings (LNTH) United States $4.303B 13.11
BillionToOne (BLLN) United States $4.147B 0.00
ICU Medical (ICUI) United States $3.806B 24.16
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.139B 14.81
Haemonetics (HAE) United States $2.758B 12.06
Neogen (NEOG) United States $2.349B 51.43
Phibro Animal Health (PAHC) United States $2.151B 18.95
Perrigo (PRGO) Ireland $2.015B 5.05
LeMaitre Vascular (LMAT) United States $1.983B 39.92
QuidelOrtho (QDEL) United States $1.977B 12.71
AtriCure (ATRC) United States $1.845B 0.00
Curaleaf Holdings (CURLF) Canada $1.622B 0.00
Kestra Medical Technologies (KMTS) United States $1.486B 0.00
Green Thumb Industries (GTBIF) United States $1.475B 64.64
AdaptHealth (AHCO) United States $1.442B 20.88
Capricor Therapeutics (CAPR) United States $1.130B 0.00
BioLife Solutions (BLFS) United States $1.080B 320.43
Lumexa Imaging Holdings (LMRI) United States $1.021B 0.00
InMode (INMD) Israel $0.953B 10.77
Tilray Brands (TLRY) Canada $0.883B 0.00
Valneva SE (VALN) France $0.817B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.803B 0.00
Omeros (OMER) United States $0.796B 0.00
CeriBell (CBLL) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.587B 15.91
Verano Holdings (VRNO) United States $0.454B 0.00
Brainsway (BWAY) Israel $0.427B 72.60
Cerus (CERS) United States $0.423B 0.00
Canopy Growth (CGC) Canada $0.405B 0.00
SNDL (SNDL) Canada $0.389B 0.00
Cresco Labs (CRLBF) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.328B 26.18
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Evolus (EOLS) United States $0.292B 0.00
Quanterix (QTRX) United States $0.284B 0.00
TriSalus Life Sciences (TLSI) United States $0.237B 0.00
Sanuwave Health (SNWV) United States $0.222B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
TerrAscend (TSNDF) Canada $0.208B 0.00
Organigram Global (OGI) Canada $0.207B 0.00
High Tide (HITI) Canada $0.207B 0.00
Utah Medical Products (UTMD) United States $0.197B 17.71
Aurora Cannabis (ACB) Canada $0.197B 58.00
OraSure Technologies (OSUR) United States $0.194B 0.00
Accendra Health (ACH) United States $0.185B 1.85
Sanara MedTech (SMTI) United States $0.180B 0.00
Vireo Growth (VREOF) United States $0.179B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.144B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.136B 0.00
Fonar (FONR) United States $0.115B 16.72
MacroGenics (MGNX) United States $0.115B 0.00
Biote (BTMD) United States $0.102B 4.46
Jushi Holdings (JUSHF) United States $0.100B 0.00
Exagen (XGN) United States $0.080B 0.00
ImmuCell (ICCC) United States $0.056B 24.00
Sharps Technology (STSS) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.042B 0.00
Rockwell Medical (RMTI) United States $0.042B 0.00
Nephros (NEPH) United States $0.041B 29.77
Veru (VERU) United States $0.038B 0.00
Modular Medical (MODD) United States $0.034B 0.00
United-Guardian (UG) United States $0.033B 16.63
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.002B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00